As demand for weight-loss injections sold under brand names such as Ozempic and Wegovy continues to soar, a study has ...
A new study compares the benefits and risks of taking GLP-1 medications for weight loss, including risks of dementia, ...
Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to reduce the ...
The findings, based on an analysis of records from 2.5 million VA patients, support much of what scientists already suspected ...
In all, researchers found that people taking GLP-1 medications had lower risks for 42 health outcomes, including liver ...
New Scientist on MSN1d
GLP-1 drugs like Ozempic and Wegovy lower the risk of 42 conditionsThe benefits of taking GLP-1 agonists seem to outweigh the risks, at least when taken for approved uses, according to an ...
T he newest weight-loss drugs, Wegovy and Zepbound, are incredibly popular. But doctors are still learning about all of the ...
GLP-1 class of weight loss and diabetes drugs are linked to previously unrecognized health risks and benefits, according to a ...
GLP-1 drugs have also demonstrated potential in reducing risks of several substance use disorders such as those involving alcohol, tobacco, cannabis, opioids and stimulants. This may be due to the ...
The Times of India on MSN1d
Not just weight loss, GLP-1 drugs like Ozempic can help with 175 conditions; says groundbreaking studyA discovery reveals that weight loss drugs like Ozempic and Mounjaro can positively impact 175 diseases and conditions beyond ...
Over 2 million people were included in new research to test these drugs against 175 different health outcomes.
A study analyzing data from over 2 million veterans found that GLP-1 receptor agonists, popular weight-loss drugs like ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback